EDITORIAL

References

• Arseneault , L. , Cannon , M. , Witton , J. and Murray , R. M. 2004 . Causal association between cannabis and psychosis: Examination of the evidence . Brit. J. Psychiatry. , 184 : 110 – 117 .
   PubMed Web of Science ®Google Scholar
• Awad , A. G. and Voruganti , L. N. P. 2005 . Neuroleptic dysphoria, comorbid drug abuse in schizophrenia and the emerging science of subjective tolerability-Towards a new synthesis . J. Dual Diagnosis. , 1 ( 2 ) : 83 – 93 .
   Google Scholar
• Brunette , M. F. , Noordsy , D. L. , Buckley , P. and Green , A. I. 2005 . Pharmacologic treatments for co-occurring substance use disorders in patients with schizophrenia: A research review . J. Dual Diagnosis. , 1 ( 2 ) : 41 – 55 .
   Google Scholar
• Chambers , A. R. Krystal , J. H. 2001 . A neurobiological basis for substance abuse comorbidity in schizophrenia . Biological Psychiatry. , 50 : 71 – 83 .
   PubMed Web of Science ®Google Scholar
• Drake , R. E. , Xie , H. , McHugo , G. J. and Green , A. I. 2000 . The effects of clozapine on alcohol and drug use disorders among schizophrenic patients . Schizophrenia Bulletin. , 26 ( 2 ) : 441 – 449 .
   PubMed Web of Science ®Google Scholar
• Green , A. I. , Zimmet , S. V. , Strous , R. D. and Schildkraut , J. J. 1999 . Clozapine for comorbid substance use disorder and schizophrenia: Do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine? . Harvard Review of Psychiatry. , 6 ( 6 ) : 287 – 296 .
   PubMed Web of Science ®Google Scholar
• Green , A. I. , Burgess , E. S. , Dawson , R. , Zimmet , S. V. and Strous , R. D. 2003 . Alcohol and canna-bis use in schizophrenia: Effects of clozapine vs. risperidone . Schizophrenia Research. , 60 : 81 – 85 .
   PubMed Web of Science ®Google Scholar
• Green , A. I. , Tohen , M. F. , Hamer , R. M. , Strakowski , S. M. , Lieberman , J. A. , Glick , I. , Clark , W. S. and HGDH Research Group. 2004 . First episode schizophrenia-related psychosis and substance use disorders: Acute response to olanzapine and haloperidol . Schizophrenia Research , 66 ( 2–3 ) : 125 – 135 .
   PubMed Web of Science ®Google Scholar
• Mueser , K. T. , Drake , R. E. , Sigmon , S. C. and Brunette , M. F. 2005 . Psychosocial Interventions for Adults with Severe Mental Illnesses and Co-occurring Substance Use Disorders: A Review of Specific Interventions . J. Dual Diagnosis, . , 1 ( 2 ) : 57 – 82 .
   Google Scholar
• O'Daly , O. G. , Guillin , O. , Tsapakis , E-M. , Martinez , D. , Shergill Sukhwinder , S. and Murray , R. M. 2005 . Schizophrenia and substance abuse co-morbidity: A role for dopamine sensitization . J. Dual Diagnosis. , 1 ( 2 ) : 11 – 40 .
   Google Scholar
• Zimmet , S. V. , Strous , R. D. , Burgess , E. S. , Kohnstamm , S. and Green , A. I. 2000 . Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: A retrospective survey . J. Clin Psychopharm. , 20 ( 1 ) : 94 – 98 .
   PubMed Web of Science ®Google Scholar